AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)
$5.87 -0.07 (-1.1785%)
Analysed AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
21-04-2026
yahoo.com
Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors
21-04-2026
yahoo.com
Maxim Sees High Risk Profile for Akari Therapeutics, plc (AKTX) Amid Capital Needs
21-04-2026
yahoo.com
Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing
20-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
10-04-2026
yahoo.com
Akari Therapeutics downgraded to Hold from Buy at Maxim
10-04-2026
yahoo.com
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC
09-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading
08-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
06-04-2026
yahoo.com
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
06-04-2026
yahoo.com
What is the current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is $5.87.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is $-0.07.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is -1.1785%.
What is the most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is .
SEC-8K** Filing Available For AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.